株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

感染症管理を促進する新しい技術

Novel Technologies Driving Infectious Disease Management

発行 Frost & Sullivan 商品コード 883627
出版日 ページ情報 英文 45 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.67円で換算しております。
Back to Top
感染症管理を促進する新しい技術 Novel Technologies Driving Infectious Disease Management
出版日: 2019年06月26日 ページ情報: 英文 45 Pages
概要

当レポートでは、感染症管理を転換する新興の診断技術市場を取り上げ、CRISPR型の診断、免疫測定法・比色分析法、分子診断、学際的技術、成長機会、および産業への影響要因などについて詳細に分析しています。

第1章 エグゼクティブサマリー

第2章 技術概要

  • 必要に応じた感染症診断の促進要因・抑制要因
  • 最新の・新しい感染症動向の概要
  • 診断技術の概要
  • 次世代の感染症検査:世界

第3章 CRISPRに基づいた迅速診断技術プラットフォーム

  • モバイル接続型のCRISPRに基づいた紙ベース診断
  • CRISPRと感染症向け合成生物学の組み合わせ

第4章 感染症向け免疫測定法・比色分析法のアップデート

  • 唾液ベースの無症候性マラリア原虫感染向け迅速診断検査
  • 敗血症の5分以内の超迅速診断
  • 5-in-1 モバイル接続型尿検査
  • ライム病診断向け改良型C6ペプチド型ELISA

第5章 必要に応じた革新的なポリメーラーゼ連鎖反応技術

  • 10分の超迅速ポリメラーゼ連鎖反応
  • 病原体特定のためのポータブルリアルタイムPCRプラットフォーム
  • 血液感染症向けの3時間以内の血液-シーケンシング結果、ほか

第6章 学際的診断プラットフォーム

  • AI、コンピューターおよびバイオインフォマティクスに基づいた診断プラットフォーム
  • 感染症向けの磁気共鳴、PCR、マイクロ流体およびNGPベースの複合型アプローチ
  • 感染症向け弾性表面波 (SAW) バイオセンサー
  • 様々な診断用途向けのナノテクノロジー、シーケンシングおよびバイオインフォマティクス

第7章 成長機会・CTA

  • 成長機会1:理想的なPOC診断検査
  • 成長機会2:分子診断
  • 成長機会3:学際的アプローチ
  • 成功・成長のための戦略インペラティブ

第8章 主な産業の影響要因

目次
Product Code: D8B4

Upcoming Technologies for Infectious Disease Diagnosis

This research service covers emerging diagnostic technologies that can transform infectious disease management.

  • CRISPR-based diagnostics: CRISPR (clustered regularly interspaced short palindromic repeats) can deliver rapid, portable and accurate diagnostics tests for field applications. This reports deals with two major US-based players developing CRISPR-based point-of-care (POC) rapid diagnostic tests which can be used with or without smartphone for detection of pathogens with improved precision.
  • Immunoassays and colorimetric tests: Immunoassays and colorimetric assays have been the most popular and conventional diagnostic tests used for rapid detection of infections. This research service shed light on some of the most recent advancements in immunoassays and colorimetric-based diagnostic tests for wide variety of infections, sepsis, malaria, Lyme Disease, and Urinary Tract Infections (UTIs).
  • Molecular Diagnostics: Polymerase chain reaction (PCR) has been proved to be the most accurate diagnostic test for genomic biomarker detection, however, its application in field as rapid diagnostic was hindered due to obvious limitations. New advancements in instruments, reagents (dry chemistry) and PCR technology are accelerating pathogen identification. This research service provide introduction to some of the most groundbreaking technologies in molecular diagnosis having great potential in field applications.
  • Multidisciplinary technologies: Developments in microfluidic technology, magnetic resonance, telecommunications, physics (surface acoustic waves) and many more are powering the exiting molecular diagnostics. Certain combinations are portrayed here.

Application of bioinformatics, artificial intelligence, and computational approaches: Next-generation sequencing (NGS) has revolutionized life sciences and healthcare. However, current laboratory-based approaches are still slow and time intensive. Advances in artificial intelligence (AI), computer programming, bioinformatics tools, and cloud technology have enabled generation of sophisticated databases. NGS along with these diverse approaches are transforming pathogen identification and provide more targeted and actionable treatments. Selected novel approached are described in this research service.

Nanopore Technology: New developments in nanotechnology are being applied to miniaturizing the devices for portable and field-based applications. Nanoscale lab-on-chip devices require minimum amount of biological sample. Nano devices are developed for NGS, detection of proteins and other biological analyte and have wide applications from clinical, agriculture to forensic and even space research. This research service summarizes two leading players and their nanopore technologies.

Table of Contents

1.0. Executive Summary

  • 1.1. Research Background: Innovating to Address the Diagnostic Gaps
  • 1.2. Research Scope: Emerging Infection Diagnostic Technologies
  • 1.3. Analysis Framework: Frost & Sullivan Core Value
  • 1.4. Research Methodology: Five Steps Toward Success
  • 1.5. Key Findings of Global Infection Diagnostic Technologies

2. Technology Snapshot

  • 2.1. Drivers and Challenges in Point of Need Infection Diagnostics
  • 2.2. Overview of Recent and Emerging Infection Diagnosis Trends
  • 2.3. Snapshot of Diagnostic Technologies
  • 2.4. Next Generation Infection Diagnostic Technologies, Global, 2019

3. CRISPR-based Rapid Diagnostic Technology Platforms

  • 3.1. Mobile Connected CRISPR-based Paper Diagnostic Tests
  • 3.2. CRISPR Combined With Synthetic Biology for Infection Diagnosis

4. Updated Immuno- and Colorimetric Assays for Infection Diagnosis

  • 4.1. Saliva-based Rapid Diagnosis Test for Subclinical Plasmodium Infections
  • 4.2. Ultra-rapid Diagnosis of Sepsis in 5 Minutes
  • 4.3. 5-in-1 Mobile Connected Urine Testing
  • 4.4. Improved C6 Peptide-based ELISA for Lyme Disease Diagnosis

5. Innovative Polymerase Chain Reaction Technologies for Point of Need Applications

  • 5.1. Ultrafast 10 Minute Polymerase Chain Reaction
  • 5.2. Portable Real-time PCR Platform for Pathogen Identification
  • 5.3. Blood-to-sequencing Results for Blood Infections Within 3 Hours
  • 5.4. Toehold Probe Multiplexed Platform for Infection Diagnosis
  • 5.5. Time Resolved Fluorescence Platform for Routine Pathogen Identification
  • 5.6. Partzymes-based Multiplex PCR for Multiple Pathogens Detection
  • 5.7. CoPrimersTM and RadioProbeTM Improve Specificity Of Diagnostic PCR

6. Multidisciplinary Diagnostic Platforms

  • 6.1. AI, Computational and Bioinformatics-based Diagnostic Platforms
  • 6.2. Magnetic Resonance, PCR, Microfluidics and NGP-based Combination Approaches for Infection Diagnosis
  • 6.3. Surface Acoustic Wave Biosensors for Infection Diagnosis
  • 6.4. Nanotechnology, Sequencing and Bioinformatics for Numerous Diagnostic Applications

7. Growth Opportunities and Companies to Action

  • 7.1. Growth Opportunity 1: Ideal Point of Care Rapid Diagnostic Test
  • 7.2. Growth Opportunity 2: Molecular Diagnostics
  • 7.3. Growth Opportunity 3: Multidisciplinary Approaches
  • 7.4. Strategic Imperatives for Success and Growth

8. Key Industry Influencers

  • 8.1. Industry Interactions-1
  • 8.2. Industry Interactions-2
  • Legal Disclaimer
Back to Top